keloid Clinical Trials

12 recruitingLast updated: May 29, 2026

There are 12 actively recruiting keloid clinical trials across 7 countries. Studies span Phase 2, Not Applicable, Phase 1, Early Phase 1, Phase 3, Phase 4. Top locations include New York, New York, United States, Farmington, Connecticut, United States, Nanjing, Jiangsu, China. Updated daily from ClinicalTrials.gov.


keloid Trials at a Glance

12 actively recruiting trials for keloid are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in New York, Farmington, and Nanjing. Lead sponsors running keloid studies include Herbarium Laboratorio Botanico Ltda, Icahn School of Medicine at Mount Sinai, and Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan.

Treatments under study

About keloid Clinical Trials

Looking for clinical trials for keloid? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new keloid trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about keloid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 3

Topical Cryotherapy and Keloid/Hypertrophic Scars

hypertrophic scarsKeloid Scars
Sonal Choudhary30 enrolled1 locationNCT07336368
Recruiting
Early Phase 1

Comparison Of Effectiveness Of Intralesional Injectioms Of 5 Flourouracil Alone Verses Its Cpmbination With Cryotherapy In The Treatment Of Keloids

keloids
Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan88 enrolled1 locationNCT07531056
Recruiting

Genetic Analysis of Keloids

keloid
UConn Health7,000 enrolled1 locationNCT01619553
Recruiting
Not Applicable

Radiotherapy for Keloids

keloid
Montefiore Medical Center15 enrolled1 locationNCT04722263
Recruiting
Phase 2

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

keloid
Icahn School of Medicine at Mount Sinai30 enrolled1 locationNCT06373458
Recruiting
Phase 1Phase 2

Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars

hypertrophic scarsSafety and EfficacyTopical Administration+3 more
Herbarium Laboratorio Botanico Ltda80 enrolled2 locationsNCT06751433
Recruiting
Phase 4

A clinical trial to compare efficacy of intralesional triamcinolone vs intralesional verapamil in patients with keloids/ hypertrophic scars.

hypertrophic scarskeloids
Noor ul Huda working as resident in khyber teaching hospital Peshawar.174 enrolled1 locationACTRN12625000568415
Recruiting
Phase 1

A Phase 1c Study Investigating the SAfety and TolErability of a LysyL Oxidase InhibiTor (PXS-6302) in the amElioration of Keloids

keloid
University of Western Australia20 enrolled1 locationACTRN12625000269437
Recruiting

Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry

Keloid Scar Following SurgeryScars, HypertrophicScar Keloid
University of Zurich20 enrolled1 locationNCT06806735
Recruiting
Phase 2

Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars

WoundkeloidWound Heal
National Skin Centre50 enrolled1 locationNCT06138964
Recruiting
Not Applicable

Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid

keloid
Nanjing First Hospital, Nanjing Medical University80 enrolled2 locationsNCT06431360
Recruiting

Web Based Investigation of Natural History of Keloid Disorder, an Online Survey

keloid
Tirgan, Michael H., M.D.10,000 enrolled1 locationNCT01423981